36932-41-9 Usage
Structure
Quinoxaline derivative with a p-tolyl-acetamide group attached to the nitrogen atom
Pharmacological activities
Antitumor, antibacterial, antiviral, and antimalarial properties
Analgesic and anti-inflammatory properties
Due to the p-tolyl-acetamide group
Potential pharmaceutical applications
As a drug candidate for various therapeutic applications
Bioactive molecules
Both quinoxaline and p-tolyl-acetamide moieties are common in bioactive molecules
Check Digit Verification of cas no
The CAS Registry Mumber 36932-41-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,6,9,3 and 2 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 36932-41:
(7*3)+(6*6)+(5*9)+(4*3)+(3*2)+(2*4)+(1*1)=129
129 % 10 = 9
So 36932-41-9 is a valid CAS Registry Number.
InChI:InChI=1/C17H17N3O2/c1-11-6-8-12(9-7-11)18-16(21)10-15-17(22)20-14-5-3-2-4-13(14)19-15/h2-9,15,19H,10H2,1H3,(H,18,21)(H,20,22)/t15-/m1/s1
36932-41-9Relevant academic research and scientific papers
Rozhkov,Ovchinnikov,Kolobov
, p. 137 - 140 (2014)
A process for preparing 3-substituted 3,4-dihydroquinoxalin-2(1H)-ones is proposed. It is based on the reaction of o-phenylenediamine with amides, di- and mono-esters of maleic acid as well as (E)-3-(5-phenyl-1,3,4-oxadiazol-2-yl) acrylic acid in the pres
